| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 26, 2016The Company Continues to Pioneer Innovations in Deep Brain Stimulation and Surgical Technologies by Launching the Only Fully-Integrated Procedural Solution for Neurosurgery
DUBLIN and SAN DIEGO - September 26, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) clearance of StealthStation® Cranial Software as an aid for deep...
-
Aug 8, 2016New Visual-Based Platform Helps Physicians Make Informed Programming Decisions by Providing an Intuitive Visualization of Patient-Specific Images and Data
DUBLIN - August 8, 2016 - Medtronic plc (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for SureTune2(TM) software, which provides patient-specific visualization to...
-
May 31, 2016Q4 Revenue of $7.6 Billion Grew 4% as Reported; 6% at Constant Currency
DUBLIN - May 31, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2016, which ended April 29, 2016. The company reported fourth quarter...
-
May 2, 2016Patients with Hydrocephalus and CSF Disorders Have Greater Access to Full Body MRI Scans with StrataMR
DUBLIN - May 2, 2016 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) clearance of StrataMR(TM) valves and shunts, an addition to Medtronic's family of...
-
Mar 1, 2016Revenue of $6.9 Billion Grew 6% on a Comparable, Constant Currency Basis; 61% as Reported
DUBLIN - March 1, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2016, which ended January 29, 2016. Unless otherwise noted, all revenue...
-
Feb 21, 2016Now Offering Both 1.5 and 3 Tesla Indications for MR-Conditional ICMs, Pacemakers, ICDs and CRT-Ds
DUBLIN - February 22, 2016 - Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for the first and only cardiac resynchronization therapy defibrillators...
-
Feb 17, 2016Approval Expands Population of Individuals Who May Benefit From the Proven Therapy
DUBLIN - February 17, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Medtronic Deep Brain Stimulation (DBS) Therapy for use in people with...
-
Dec 14, 2015Live On. Give On: Medtronic Philanthropy Provides MedTech Patients with $20,000 Grant to Direct to a Charitable Cause of Their Choice
DUBLIN - December 14, 2015 - Medtronic (NYSE: MDT) announced today that 12 people representing 11 countries will be honored with the 2015 Bakken Invitation Award, which recognizes people who have...
-
Dec 9, 2015Updated Labeling Allows Greater Patient Access to MRI, a Critical Diagnostic Tool
DUBLIN - December 9, 2015 - Medtronic plc (NYSE: MDT) today announced that systems within its Activa® portfolio of Deep Brain Stimulation (DBS) neurostimulators have received FDA approval for...
-
Dec 3, 2015Revenue of $7.1 Billion Grew 6% on a Comparable, Constant Currency Basis; 62% as Reported
DUBLIN - December 3, 2015 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2016, which ended October 30, 2015. Unless otherwise noted, all...